Xujia Yan

National Institutes For Food And Drug Control NHC Key Laboratory Of Research On Quality And Standardization Of Biotech Products, NMPA Key Laboratory For Quality Research And Evaluation Of Biological Products Beijing People's Republic Of China
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.

Journal: Signal transduction and targeted therapy

Published: January 10, 2023

Mixed formulation of mRNA and protein-based COVID-19 vaccines triggered superior neutralizing antibody responses.

Mixed formulation of mRNA and protein-based COVID-19 vaccines triggered superior neutralizing antibody responses.

Journal: MedComm

Published: September 05, 2022

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques.

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques.

Journal: Frontiers in immunology

Published: May 20, 2022

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV.

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV.

Journal: Emerging microbes & infections

Published: March 28, 2022

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains.

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains.

Journal: Human vaccines & immunotherapeutics

Published: November 10, 2021

Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.

Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.

Journal: Signal transduction and targeted therapy

Published: November 08, 2021

Construction and verification of an infectious cDNA clone of coxsackievirus B5.

Construction and verification of an infectious cDNA clone of coxsackievirus B5.

Journal: Virologica Sinica

Published: September 07, 2021

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.

Journal: Vaccine

Published: July 27, 2021

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.

Journal: Emerging microbes & infections

Published: July 19, 2021

High hepatitis E virus antibody positive rates in dogs and humans exposed to dogs in the south-west of China.

High hepatitis E virus antibody positive rates in dogs and humans exposed to dogs in the south-west of China.

Journal: Zoonoses and public health

Published: April 08, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026